Robert K



Paul John Rochon, MD

1746 Locust Street Department of Radiology L954

Denver, CO 80220 12401 E. 17th Avenue, Rm 541

Home: (303) 955-1864 Aurora, CO 80045

Mobile: (786) 422-4523 work: (720) 848-6617

Paul.Rochon@ucdenver.edu fax: (720) 848-7315

Citizenship: U.S.A.

Marital Status: Married

Birthplace: Lafayette, LA

Education

University of Louisiana-Lafayette

Lafayette, LA

B.S., 1999

Louisiana State University Health Sciences Center

New Orleans, LA

M.D. 2004

Medicine Internship

Louisiana State University

New Orleans, LA

2004-2005

Diagnostic Radiology Residency

Louisiana State University

New Orleans, LA

2005-2006

Diagnostic Radiology Residency

University Hospitals - Case Western Reserve University

Cleveland, OH

2006-2009

Vascular and Interventional Radiology Fellowship

Miami Vascular Institute

Miami, FL

2009-2010

Academic Appointments

Associate Professor of Radiology

University of Colorado School of Medicine

July 2016 to present

Assistant Professor of Radiology

University of Colorado School of Medicine

Aug 2010 to July 2016

Division of Interventional Radiology

Director of Noninvasive Imaging – 2010 to 2015

Director of Fellowship Program – 2012 to present

Co-Director of Hereditary Hemorrhagic Telangiectasia – 2015 to present

Master of Science in Modern Human Anatomy Program

Clinical Director – 2013 to present

Honors, Special Recognitions and Awards

Operative and Perioperative Care Medical Student Rotation Faculty of the Year Finalist - 2017

Radiological Society of North America Education Exhibit Magna Cum Laude Award

2016

University of Colorado School of Medicine Excellence in Teaching and Mentorship of Medical Students Award

2015

Society of Interventional Radiology Distinguished Abstract

2015

Siemens AUR Radiology Resident Academic Development Program

2007

Radiological Society of North America School Departmental Grant Recipient

2001

Phi Kappa Phi Graduate Fellowship

1998

Phi Beta Kappa Award

1999

UL-Lafayette Outstanding Graduate Award

1999

National Institutes of Health Undergraduate Scholarship

1998-1999

American Society for Microbiology Research Fellowship

1997

Administrative, Committee, and Society Service

National

Society of Interventional Radiology (SIR)

Student and Resident Education Committee Vice Chair (2010-present)

Association of Program Directors in Interventional Radiology (2012-present)

American College of Radiology

Appropriateness Criteria Expert Panel on Interventional Radiology (2011-present): Evidence based guidelines to assist referring physicians and other providers in making the most appropriate imaging or treatment decision for a specific clinical condition. Employing these guidelines helps providers enhance quality of care and contribute to the most efficacious use of radiology.

Interventional Radiology Committee of the Education Commission (2012-present)

American Roentgen Ray Society

SHERPA Task Force (2012-present): assisting the in the development of curricula and educational resources for Interventional Radiology

Scientific Program Subcommittee Team (2012-present)

American Registry for Diagnostic Medical Sonography (2010-present)

School of Medicine

University of Colorado Masters of Modern Human Anatomy

Clinical Director (2013-present)

University of Colorado Medical Student Promotions Committee

Voting Member (2013-present)

University of Colorado Medical Student Admissions Committee

Lecturer and Interviewer (2011-present)

Departmental

University of Colorado Department of Radiology Education Committee

Board Certification and Licensure

Diagnostic Radiology 2009

American Board of Radiology

Certificate of Added Qualification 2012

Vascular and Interventional Radiology

American Board of Radiology

Colorado Medical License 2010 - Present

Florida Medical License 2009 - 2014

Registered Physician in Vascular Interpretation 2010 – Present

Review and referee work

Journal of Vascular and Interventional Radiology (JVIR) Reviewer (2010-present)

American Roentgen Ray Society Annual Scientific Program Abstract and Exhibit Reviewer (2013, 2014)

National Meeting Session Coordinator/Moderator

1. Interventional Radiology Residency Workshop. Society of Interventional Radiology March 2014. San Diego, CA.

2. Interventional Radiology for the Diagnostic Radiologist. American Roentgen Ray Society May 2014. San Diego, CA.

3. The IR Residency: Curriculum Development. Society of Interventional Radiology. March 2015. Atlanta, GA.

4. Interventional Radiology for the Diagnostic Radiologist. American Roentgen Ray Society. April 2015. Toronto, CA.

5. Radiation Protection in the Interventional Radiology Suite. Society of Interventional Radiology. April 2016. Vancouver, BC.

6. Management of Chronic Venous Disease. Society of Interventional Radiology. April 2016. Vancouver, BC.

7. Survival Tips in the New Era of Interventional Radiology. April 2016. Los Angeles, CA.

Invited Meeting Faculty

Local

1. Interesting Cases Across IR. Rocky Mountain Vascular and Interventional Radiology Technologists Meeting, October 2011 Aurora, CO.

2. MRI/MRA of the Peripheral Vascular System. First Annual UCH MRI Symposium. Oct 2013, Aurora, CO.

3. Management of Vascular Malformations. Southwest Fellows Symposium. May 2015, Aurora, CO.

4. Trends in the Management of Endoleaks. Mile High Aortic Tech Exchange. November 2015. Aurora, CO.

National

1. Interventional Radiology for the Diagnostic Radiologists. American Roentgen Ray Society May 2012, Vancouver, CA.

2. Ultrasound guided interventions. American Institute of Ultrasound in Medicine. April 2013, New York, NY.

3. Vascular Complications. American Roentgen Ray Society April 2013, Washington, DC.

4. Interventional Radiology Oncology Case Based Review. American Roentgen Ray Society April 2013, Washington, DC.

5. Interventional Radiology Practice Building. Contemporary Interventional Radiology Jan 2014, Hollywood, CA.

6. Working in an Academic Setting. International Symposium of Endovascular Therapy Jan 2014, Miami, FL.

7. Inferior Vena Cava Filter Workshop. Society of Interventional Radiology March 2014. San Diego, CA.

8. Interventional Radiology Cased-Based Review: Arterial Therapy. American Roentgen Ray Society May 2014. San Diego, CA.

9. Interventional Radiology Residency Model. Association of Program Directors in Interventional Radiology. October 2014. Scotsdale, AZ.

10. Approach to Lower Extremity Swelling. International Symposium on Endovascular Therapy. February 2015. Hollywood, FL

11. Emergency Room Evaluation of a Cold Leg. International Symposium on Endovascular Therapy. February 2015. Hollywood, FL.

12. How I Do It: Inferior Vena Cava Thrombus and Pulmonary Emboli. International Symposium on Endovascular Therapy. February 2015. Hollywood, FL.

13. Working in an Academic Setting. International Symposium on Endovascular Therapy. February 2015. Hollywood, FL.

14. Vascular Malformations. Contemporary Interventional Radiology. Februrary 2015. Los Angeles, CA.

15. Developing a Dedicated Venous Thromboembolism Service Line. Society of Interventional Radiology. March 2015. Atlanta, GA.

16. Liquid Embolic Workshop. Society of Interventional Radiology. March 2015. Atlanta, GA.

17. The Interventional Radiology (IR) Domain – Case Based Review: Arterial Therapy. Society of Interventional Radiology. March 2015. Atlanta, GA.

18. Palliative Care in Interventional Radiology. American Roentgen Ray Society. April 2015. Toronto, CA.

19. Value of IR. Medical Student in Training/Resident in Training Scholarship Dinner Keynote Lecture. Society of Interventional Radiology. April 2016. Vancouver, BC.

20. Trends and Future Directions in Radiation Safety. Society of Interventional Radiology. April 2016. Vancouver, BC.

21. Complications of Chronic Venous Occlusion Disease Management Therapies. April 2016. Vancouver, BC.

22. Practice Building in Academic IR. American Roentgen Ray Society. April 2016. Los Angeles, CA.

23. Transition of Fellowship to IR Residency: Medium Size Program. Association for Program Directors in Interventional Radiology. October 2016. Orlando, FL.

24. Clinical and Imaging Assessment of the Failing Dialysis Access. Radiological Society of North America. November 2016. Chicago, IL.

25. Permanent vs retrievable: rethinking the “one-filter-for-all” approach to filter utilization. Presenter and Co-Author. Society of Interventional Radiology. March 2017. Washington, DC.

26. Comparing Overall Survival in Patients with Hepatocellular Carcinoma Treated with Drug Eluting Embolic Chemoembolization with or without Portal Vein Thrombus. Co-Author. Society of Interventional Radiology. March 2017. Washington, DC.

27. Racial disparities in dialysis access maintenance intervention outcomes in the Medicare population: a longitudinal 5-year evaluation following primary access placement. Co-Author. Society of Interventional Radiology. March 2017. Washington, DC.

28. Comparative outcomes of percutaneous endovascular dialysis access maintenance interventions by provider specialty: a 5-year Medicare study. Co-Author. Society of Interventional Radiology. March 2017. Washington, DC.

29. National volume trends of dialysis access maintenance interventions by provider specialty: analysis of the 2009-2014 Medicare 5% sample. Co-Author. Society of Interventional Radiology. March 2017. Washington, DC.

30. Compelling Conversations -Mentorship: Making it Work. Society of Interventional Radiology. March 2017. Washington, DC.

31. Vascular Malformations: A Practical Approach to Lower Extremity Vascular Malformations. Society of Interventional Radiology. March 2017. Washington, DC.

32. The IR Domain – Peripheral Artery Disease: Critical Limb Ischemia. Society of Interventional Radiology. March 2017. Washington, DC.

Scientific/Educational Exhibits

1. Rochon P. Bacterial Responses to the Membrane Attack Complex of Complement Ronald E. McNair Research Internship Program 1998 Lafayette, LA.

2. Rochon P, Dankert J. The Ability of the C5b-9 Complex to Kill Gram-negative Bacteria is not Inhibited by CD59. American Society for Microbiology 1997 Atlanta, GA.

3. Rochon P, Roger MJ, McCutcheon T. The Translational Apparatus of the Malaria Parasite: Drug Target and Developmental Regulation. National Institutes of Health 1997 Bethesda, MD.

4. Rochon P, Dankert J. Effect of Human CD59 on Complement-Mediated Killing of Bacteria. American Society for Microbiology 1999 New Orleans, LA.

5. Rochon P, Nagaraju K, Plotz P. “Do Apoptotically­Cleaved Autoantigens Induce Autoimmune Disease?” National Institutes of Health 1999 Bethesda, MD.

6. Rochon P, Nagaraju K, Plotz P. “Do Apoptotically­Cleaved Autoantigens Induce Autoimmune Disease?” American Medical Student Association 2000 Washington, D.C.

7. Martin C, Rochon P, Kang P, Jean-Claude J, Pinault G. Long-term Results Following Infrainguinal Atherectomy using the Silverhawk Atherectomy Device International Symposium on Endovascular Therapy. January 17-22, 2009. Hollywood, FL.

8. Oppenheimer J, Ray C, Gupta R, Kondo K, Rochon P, Durham J. Pulmonary vascular anatomy: implications for interventions. American Roentgen Ray Society Annual Meeting, Chicago, IL, May 2011.

9. Ray CE Jr, Oppenheimer J, Gupta R, Rochon P, Kondo K, Durham J. Liver abscess – the role of interventional radiology. Cardiovascular and Interventional Radiology Society of Europe, Munich, Germany, September 2011.

10. Ahmed F*, Ray C, Hess E, Kondo K, Gupta R, Peyton B, Rochon P, Durham J. What variables predict the need for revisions in patients undergoing TIPS with PTFE-covered stents? Society of Interventional Radiology Annual Meeting, Chicago, IL, March 2011.

11. Ray C, Campsen J, Gupta R, Kondo K, Rochon P, Cook B, Kaufman C, Kaplan M, Zimmerman M, Kam I, Durham J. Stenting of the IVC following liver transplantation: an update. Society of Interventional Radiology Annual Meeting, Chicago, IL, March 2011.

12. Dines M*, Ray C, Durham J, Gupta R, Rochon P, Babson K, Kondo K. Hepatocellular carcinoma in patients with hepatitis C and other causes. American Roengten Ray Annual Meeting May 2012. (Refereed Published Abstract 198:198_5_Supplement_E638).

13. Bell MT*, Reece TB, Jazaeri O, Gupta R, Rochon PJ. Endovascular management of aortic atheromatous disease. International Symposium of Endovascular Therapy Miami, FL, Jan 2013.

14. Lindsay AJ*, Rochon PJ, Graybill K, Kondo K, Gipson M, Smith M, Durham J, Ray Jr C. Easy access – port placement principles and management for the resident and mid-level trainee. Cardiovascular and Interventional Radiology Society of Europe Barcelona, Spain Sept 2013.

15. Brown A*, Rochon P, Smith M, Ray C, Gipson M, Kondo K, Durham J. Not just another tube: principles of gastrostomy and gastrojejunostomy tube placement for the interventional radiology trainee. Cardiovascular and Interventional Radiology Society of Europe Barcelona, Spain Sept 2013.

16. Gipson MG*, Kumpe DK, Ray Jr C, Rochon PJ. N-butyl cyanoacrylate and coil embolization in the setting of unilateral pulmonary artery agenesis in a patient with massive hemoptysis. Cardiovascular and Interventional Radiology Society of Europe Barcelona, Spain Sept 2013.

17. Schramm KM*, Cook B, Kondo K, Imbrogno B, Rochon P. Informed Consent in Interventional Radiology: Resident Attitudes and Response to Education. American College of Radiology National Meeting, Washington DC May 2016

18. Rigual D*, Rochon P. IR Management of Complications of Laparoscopic Pancreaticoduodenectomy. Magna Cum Laude Award. Radiological Society of North America. November 2016. Chicago, IL.

19. Rochon P, Schramm K*. Ultrasound guided Contraceptive Explantation: A Niche for the Interventionalist. American Institute for Ultrasound in Medicine, Orlando March 2017.

20. Smith J*, Rochon P, Kondo K, Caldwell J, Orr Caley. “TIPS” for developing a learning module on Transjugular Intrahepatic Portosystemic Shunt (TIPS) Creation. Modern Human Anatomy Program Capstone Poster Presentation, University of Colorado Anschutz Medical Campus, April 2017.

Teaching Record

University of Colorado Department of Radiology

Fellowship Program Director – Interventional Radiology (2012- present)

Developer and Co-Coordinator, Multidisciplinary Vascular Conference (2011-present)

Developer and Coordinator, Interventional Radiology Nurse and Technologist Lecture Series (2011-present)

Developer of University of Colorado Interventional Radiology Medical Student Symposium

Grants/Clinical Trials/Registries

Grants

Society of Interventional Radiology Foundation Grant (2-5-16072)

Title: National comparative trends in utilization of percutaneous endovascular dialysis access maintenance procedures by provider specialty, associated complications and long term patency rates using Medicare 5% files.

Faculty Sponsor: Paul J. Rochon, MD

Resident PI: Premal Trivedi, MD

Awarded: 10/1/15

Funding: $30,000

Percent effort: 40%

Clinical Trials

ACCelerated Thrombolysis for Post-Thrombotic Syndrome Using the EKOS System (ACCESS PTS)

Site Principal Investigator: Thor Johnson, MD

Site Sub Investigator: Paul J. Rochon, MD

Percent effort: 5%

• Sponsor: EKOS Corporation (multi-center trial)

• Purpose of study: To evaluate the efficacy of ultrasound accelerated thrombolysis using the EkoSonic® Endovascular System with standard infusion of thrombolytic drug for post-thrombotic syndrome and chronic venous occlusion.

• NCT # NCT02159521

PRESERVE (Predicting the Safety and Effectiveness of Inferior Vena Cava Filters)

Site Principal Investigator: Paul J. Rochon, MD

Status: IRB Approved. Now at Office of Grants and Contracts

Funding: $20,000/year

Percent effort: 10%

• First large-scale, multispecialty prospective clinical research trial to evaluate the use of inferior vena cava (IVC) filters and related follow-up treatment in the United States—initiated by a collaboration between the Society of Interventional Radiology (SIR) and the Society for Vascular Surgery (SVS).

• Predicting the Safety and Effectiveness of Inferior Vena Cava Filters (PRESERVE) will directly address an August 2010 FDA medical alert detailing the possibility that retrievable IVC filters could move or break, potentially causing significant health risks for patients.

The study will have the goal of obtaining a real-world view of the safety and effectiveness of most filters placed in the United States.

BEST CLI Trial (Best Endovascular vs Best Surgical Therapy in Patients with Critical Limb Ischemia)

Site Prinicipal Investigator: Kevin Rogers, MD

Site Sub Investigator: Paul J. Rochon, MD

Status: Enrolling

Percent effort: 5%

• This study will compare the effectiveness of best available surgical treatment with best available endovascular treatment in adults with critical limb ischemia (CLI) who are eligible for both treatment options.

Phase 1 trial of IPI-926 plus cetuximab in head and neck squamous cell carcinoma

Site Principal Investigator: Antonio Jimeno, MD

Site Sub Investigator: Paul J. Rochon, MD

Status: Completed, Manuscript accepted

Percent effort: 5%

• Only a limited number of patients with relapsed/metastatic head and neck squamous cell carcinoma (HNSCC) benefit from anti-EGFR antibodies (i.e. cetuximab). Preclinically, hedgehog pathway (HhP) inhibition synergizes with EGFR blockade in vitro and in patient-derived xenografts. This phase 1 study combined cetuximab and IPI-926, a HhP inhibitor, in patients with relapsed/metastatic HNSCC. Patients underwent three serial tumor biopsies before and during treatment. The maximal tolerated dose of IPI-926 was 160 mg. Among 9 treated, 8 evaluable patients, the best responses were 1 partial response (12.5%), 4 stable disease (50%), and 3 disease progressions (37.5%). The median progression free survival was 77 days (95% confidence interval 39-156). Decreases in tumor size were seen in both cetuximab-naïve patients (one HPV-positive, one HPV-negative). Toxicity was consistent with prior single agent IPI-926 and cetuximab trials. Clinical benefit was strongly associated with intra-tumoral ErbB and HhP gene expression down-regulation during therapy, supporting the preclinical hypothesis.

Veins for Life 2

Site Principal Investigator: Paul J. Rochon, MD

Status: On Hold due to rewriting of protocol

• This study will compare prospective safety and quality of life outcomes in patients receiving chemotherapy via either port or peripheral IV. It will also explore patients’ reasons behind choice for a vascular access device and patient satisfaction with the choice of a vascular access device.

Registries

Registry of Angiovac Procedures in Detail Outcomes Database (RAPID)

Site Principal Investigator: Paul J. Rochon, MD

Status: Open

Funding: $300/year

Percent effort: 10%

• Sponsor: Angiodynamics

Purpose: To collect information on the Angiovac procedure and Angiovac device used in the treatment of deep venous thrombosis (DVT), right heart pathology and pulmonary embolism.

Worldwide Therapeutic Embolization Cohort Post Market Registry: EmboCoH

Site Principal Investigator: Paul J. Rochon, MD

Status: Open

Funding: None

Percent effort: 10%

Protocol Number: 16-2481

• This study is collecting information on patients who have had a repair of a visceral artery aneurysm. This information will go into a registry and will help make this repair procedure better in the future.

Referred Publications

* Denotes trainee

** Denotes peer-reviewed web-based publications

1. Nagaraju K, Casciola-Rosen L, Rosen A, Thompson C, Loeffler L, Parker T, Danning C, Rochon PJ*, Gillespie J, Plotz P. The inhibition of apoptosis in myositis and in normal muscle cells. J Immunol. 2000 May 15;164(10):5459-65. 20261690

2. Nagaraju K, Raben N, Loeffler L, Parker T, Rochon PJ*, Lee E, Danning C, Wada R, Thompson C, Bahtiyar G, Craft J, Hooft Van Huijsduijnen R, Plotz P. The conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies. Proc Natl Acad Sci USA. 2000 Aug 1;97(16):9209-14. 20381362

3. Etezadi V, Gandhi RT, Benenati JF, Rochon P*, Gordon M, Benenati MJ, Alehashemi S, Katzen BT, Geisbusch P. Endovascular treatment of visceral and renal artery aneurysms. J Vasc Interv Radiol. 2011 Sep;22(9):1246-53. 21741856

4. Jazaeri O, Gupta R, Rochon PJ, Reece TB. Endovascular approaches and perioperative consideration in acute aortic dissection. Semin Cardiothorac Vasc Anesth. 2011 Dec;15(4):141-62. 2219428d

5. **Darcy M, Ray C, Lorenz J, Burke C, Fidelman N, Greene F, Hohenwalter E, Kinney T, Kolbeck K, Kostelic J, Kouri B, Nair A, Owens C, Rochon P, Rockey D, Vatakencherry G. “ACR Appropriateness Criteria: Radiologic Management of Lower Gastrointestinal Tract Bleeding.” Web. Am Coll Radiol. 2011.

6. **Lorenz J, Ray C, Burke C, Darcy M, Fidelman N, Greene F, Hohenwalter E, Kinney T, Kolbeck K, Kostelic J, Kouri B, Nair A, Owens C, Rochon P, Rockey D, Vatakencherry G. “ACR Appropriateness Criteria: Radiologic Management of Infected Fluid Collections.” Web. Am Coll Radiol 2011. ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download